CUR-1916 (changed from previous name: ANAT platform)
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Pipeline Type
New Drugs in Development
Phase Of Development
Preclinical
Sponsors and Collaborators
OPKO
Mechanism of Action
RNA Therapy
Mechanism Description
anti-Natural Antisense Transcripts to upregulate gene production
Populations Tested In
Dravet syndrome
Other Resources
Special FDA Designation
Nonprofit or Government Support
N/A
Nonprofit or Government Support Description
N/A
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link